Award recordCONTRACT

BIOCRYST PHARMACEUTICALS INC

PIID 36C26124N0446· VHA· 261-NETWORK CONTRACT OFFICE 21 (36C261)· 6505 · DRUGS AND BIOLOGICALS· FY2024· $0 net obligations· UEI MGXADJ6SCLJ5· NC

Description

BEROTRALSTAT

First action · last action
2024-02-16 · 2024-11-25
Transactions
2
First transaction's obligation
$29,650
Base + all options value (sum of deltas)
$0
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79721D0166
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$29,650$0Base award · 2024-02-16 · this action $29,650 · running total $29,650Modification P00002 · 2024-11-25 · this action -$29,650 · running total $0
  • Base2024-02-16+$29,650= $29,650
  • Mod P000022024-11-25-$29,650= $0
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2024-02-16+$29,650$29,650BEROTRALSTAT
Mod P00002· FUNDING ONLY ACTION2024-11-25−$29,650$0BEROTRALSTAT

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI MGXADJ6SCLJ5)

AwardOffice · PSC / listingNet obligationsFY
36E79726A0015NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C24926F0152249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$30,293FY2026
36C26026F0294260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$151,465FY2026
36C26026F0006260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$360,000FY2026
36C26025F0296260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$29,408FY2025
36C26025F0070260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$242,987FY2025

Other recipients under 6505 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26126P1178OPTUM FRONTIER THERAPIES II, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,374FY2026
36C26126P1102ENVIGO RMS LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$74,586FY2026
36C26126P096110X GENOMICS, INC.261-NETWORK CONTRACT OFFICE 21 (36C261)$34,600FY2026
36C26126P0997SIERRA RADIOPHARMACY LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$247,204FY2026
36C26126P1008OPTUM FRONTIER THERAPIES II, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,374FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26124N0446_3600_36F79721D0166_3600 · retrieved 2026-09-26.